Legal Representation
Attorney
Anne E. Naffziger
USPTO Deadlines
Application History
41 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 1, 2020 | ABN0 | O | ABANDONMENT - INCOMPLETE RESPONSE |
| Jul 1, 2020 | MAB0 | O | ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE |
| Jun 10, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 10, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jun 9, 2020 | ALIE | A | ASSIGNED TO LIE |
| Jun 4, 2020 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Dec 5, 2019 | CNFR | W | SU - FINAL REFUSAL - WRITTEN |
| Dec 5, 2019 | GNFR | O | FINAL REFUSAL E-MAILED |
| Dec 5, 2019 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Nov 13, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Nov 13, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Nov 9, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Oct 23, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 10, 2019 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
| May 10, 2019 | GNRT | O | NON-FINAL ACTION E-MAILED |
| May 10, 2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Apr 25, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Apr 24, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Apr 24, 2019 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Apr 24, 2019 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
| Apr 18, 2019 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
| Apr 18, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 18, 2019 | EXT2 | S | SOU EXTENSION 2 FILED |
| Apr 18, 2019 | IUAF | S | USE AMENDMENT FILED |
| Oct 26, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Oct 24, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 24, 2018 | EXT1 | S | SOU EXTENSION 1 FILED |
| Oct 24, 2018 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Apr 24, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Feb 27, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Feb 27, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Feb 7, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jan 22, 2018 | ALIE | A | ASSIGNED TO LIE |
| Jan 12, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 12, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jan 12, 2018 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Jan 12, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Jan 12, 2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jan 12, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Oct 11, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 7, 2017 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
biochemicals, namely, monoclonal antibodies for in vitro scientific or research use
First Use Anywhere:
Feb 29, 2016
First Use in Commerce:
Feb 29, 2016
Class 005
biological preparations for the treatment of cancer and inflammation
First Use Anywhere:
Feb 29, 2016
First Use in Commerce:
Feb 29, 2016
Classification
International Classes
001
005
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO